Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MIAMI, Dec. 01, 2023 (GLOBE NEWSWIRE) Avenue Therapeutics, Inc. (NASDAQ:ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of therapies for the
Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
In a notable insider transaction, ROSENWALD LINDSAY A MD, the President, CEO & Chairman, and 10% Owner of Fortress Biotech Inc, has recently increased his stake in the company.
Fortress Biotech, Inc. (NASDAQ:FBIO – Get Free Report) CEO Lindsay A. Md Rosenwald acquired 1,567,515 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The shares were purchased at an average cost of $1.70 per share, for a total transaction of $2,664,775.50. Following the completion of the acquisition, the chief executive officer […]